Cable Hill Partners’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $277K | Buy |
|
|||||
|
2024
Q4 | $285K | Hold |
|
|||||
|
2024
Q3 | $304K | Sell |
|
|||||
|
2024
Q2 | $357K | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $386K | Buy |
|
|||||
|
2023
Q2 | $375K | Hold |
|
|||||
|
2023
Q1 | $421K | Sell |
|
|||||
|
2022
Q4 | $481K | Buy |
|
|||||
|
2022
Q3 | $392K | Buy |
|
|||||
|
2022
Q2 | $359K | Hold |
|
|||||
|
2022
Q1 | $334K | Hold |
|
|||||
|
2021
Q4 | $383K | Hold |
|
|||||
|
2021
Q3 | $335K | Hold |
|
|||||
|
2021
Q2 | $361K | Hold |
|
|||||
|
2021
Q1 | $327K | Hold |
|
|||||
|
2020
Q4 | $380K | Hold |
|
|||||
|
2020
Q3 | $329K | Hold |
|
|||||
|
2020
Q2 | $534K | Hold |
|
|||||
|
2020
Q1 | $366K | Hold |
|
|||||
|
2019
Q4 | $366K | Hold |
|
|||||
|
2019
Q3 | $292K | Sell |
|
|||||
|
2019
Q2 | $377K | Hold |
|
|||||
|
2019
Q1 | $391K | Sell |
|
|||||
|
2018
Q4 | $379K | Hold |
|
|||||
|
2018
Q3 | $440K | Buy |
|
|||||
|
2018
Q2 | $414K | Hold |
|
|||||
|
2018
Q1 | $334K | Hold |
|
|||||
|
2017
Q4 | $397K | Sell |
|
|||||
|
2017
Q3 | $414K | Buy |
|
|||||
|
2017
Q2 | $398K | Hold |
|
|||||
|
2017
Q1 | $386K | Hold |
|
|||||
|
2016
Q4 | $364K | Hold |
|
|||||
|
2016
Q3 | $408K | Hold |
|
|||||
|
2016
Q2 | $359K | Hold |
|
|||||
|
2016
Q1 | $373K | Hold |
|
|||||
|
2015
Q4 | $461K | Hold |
|
|||||
|
2015
Q3 | $484K | Hold |
|
|||||
|
2015
Q2 | $602K | Buy |
|
|||||
|
2015
Q1 | $484K | Buy |
|
|||||
|
2014
Q4 | $271K | Buy |
|